Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated <i>NPM1</i> and <i>TET2</i>
-
- Saito Kenki
- Department of Hematology/Oncology, Kurashiki Central Hospital, Japan
-
- Sato Takayuki
- Department of Hematology/Oncology, Kurashiki Central Hospital, Japan
-
- Notohara Kenji
- Department of Anatomic Pathology, Kurashiki Central Hospital, Japan
-
- Nannya Yasuhito
- Department of Pathology and Tumor Biology, Kyoto University, Japan Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Japan
-
- Ogawa Seishi
- Department of Pathology and Tumor Biology, Kyoto University, Japan
-
- Ueda Yasunori
- Department of Hematology/Oncology, Kurashiki Central Hospital, Japan
Search this article
Abstract
<p>Bone marrow necrosis (BMN) has various underlying diseases. In hematological malignancies, both lymphoid and myeloid neoplasms have been shown to cause BMN. Charcot-Leyden crystals (CLCs) are bipyramidal crystals that have been found in patients with immune system diseases, tumors, skin diseases, asthma, infections, and intestinal diseases. Because the combination of CLCs and acute myeloid leukemia (AML) is rare, the relationship between BMN, CLCs, and AML remains largely unexplored. We herein report a suspected case of AML that was difficult to diagnose morphologically because of complete BMN with CLCs but achieved complete hematologic remission with treatment similar to that for AML. </p>
Journal
-
- Internal Medicine
-
Internal Medicine 61 (21), 3265-3269, 2022-11-01
The Japanese Society of Internal Medicine
